SEC Form 4 · accession 0001104659-15-064977
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Joslyn
Director
Period of report
Sep 11, 2015
Accepted (ET)
Sep 14, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 11, 2015 | M | 13,754 | $3.95 | A | 13,754 | D | |
| Common Stock | Sep 11, 2015 | S | 500 | $7.24 | D | 13,254 | D | |
| Common Stock | Sep 11, 2015 | S | 3,300 | $7.23 | D | 9,954 | D | |
| Common Stock | Sep 11, 2015 | S | 9,954 | $7.22 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $3.95 | Sep 11, 2015 | M | 13,754 | D | — | Aug 7, 2022 | Common Stock | 13,754 | 196,520 | D |
Explanation of responses
- F1Fully vested.